Today: 10 June 2026
Browse Category

NASDAQ:LPTX 13 November 2025 - 10 December 2025

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies (CYPH) Stock: Zcash Treasury Pivot, Winklevoss Backing and 2026 Forecast Explained

Cypherpunk Technologies Inc. (NASDAQ: CYPH), formerly Leap Therapeutics, closed at $1.62 on December 9, 2025, up nearly 40% after pivoting from biotech to a Zcash-focused treasury strategy backed by Winklevoss Capital. The stock has seen trading halts, insider sales, and sharp volatility since the rebrand and $58.88 million private placement in October.
10 December 2025
·····
Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

Cypherpunk Technologies (LPTX → CYPH) Soars on Winklevoss‑Backed $50M Zcash Bet as Ticker Changes Today

Leap Therapeutics rebranded as Cypherpunk Technologies Inc. and changed its Nasdaq ticker from LPTX to CYPH on November 13, 2025. The company raised $58.88 million in a private placement led by Winklevoss Capital and spent $50 million buying 203,775 Zcash. Shares surged up to 440% after the announcement, with LPTX trading near $2.05 and ZEC at $502 early Thursday. Q3 results show a sharply reduced net loss as biotech spending falls.
13 November 2025
···

Stock Market Today

  • U.S. Stock Futures Fall Amid Iran Strikes and Inflation Concerns
    June 10, 2026, 9:04 AM EDT. Nasdaq futures declined over 1% as former President Donald Trump warned of further actions against Iran following recent strikes. Investors also braced for upcoming Consumer Price Index (CPI) data, with economists forecasting inflation to surpass a critical threshold. The developments heightened market jitters, impacting investor sentiment ahead of key economic releases.

Latest articles

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

BlackBerry Drops Again; QNX Gains on the Line With June Earnings Ahead

10 June 2026
BlackBerry shares dropped 4.84% to $8.84 Tuesday and slid further to $8.42 premarket Wednesday, erasing part of a 49% rally as investors question whether QNX and Secure Communications growth can justify recent gains ahead of Q1 fiscal 2027 earnings on June 25; the stock is now down 14.5% from last week’s close.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

10 June 2026
Nuvalent soared 39.28% to $123.25 after GSK agreed to buy the company for $124 per share in cash, leaving a narrow 0.6% spread as investors shift focus to the $10.6 billion merger’s tender-offer timing, antitrust review, and FDA decision dates for two lung-cancer drugs in September and November 2026.
Go toTop